Search Results - "DeJesus, Yvette"

Refine Results
  1. 1
  2. 2

    Abstract 3434: An evaluation of laboratory data at admission for predicting mortality among critically ill patients with cancer by Cheng, Lee, DeJesus, Yvette, Rodriguez, Alma M.

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…BACKGROUND: Accurately estimating the life expectancy of patients with metastatic or advanced cancer is a crucial step to planning appropriate palliative or…”
    Get full text
    Journal Article
  3. 3

    Chemotherapy use during the last 30 days of life in patients with cancer by Rodriguez, Maria Alma, DeJesus, Yvette, Cheng, Lee

    Published in Journal of clinical oncology (01-12-2012)
    “…Abstract only 231 Background: Treatment options are increasingly available to patients with advanced cancer. Appropriately timed cession of chemotherapy is a…”
    Get full text
    Journal Article
  4. 4

    Chemotherapy within the last 30 days of life among patients with metastatic solid tumors by Rodriguez, Maria Alma, DeJesus, Yvette, Cheng, Lee, Burke, Thomas W.

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e16574 Background: Metastatic solid tumors (MST) are rarely curable. However, treatment options for MST (stage IV) are increasing. Thus,…”
    Get full text
    Journal Article
  5. 5

    Infusion site soft-tissue injury after paclitaxel administration by Bicher, A, Levenback, C, Burke, T W, Morris, M, Warner, D, DeJesus, Y, Gershenson, D M

    Published in Cancer (01-07-1995)
    “…Paclitaxel is a diterpenic plant product that has significant activity in several solid tumors, including epithelial ovarian cancer. After promising results in…”
    Get more information
    Journal Article
  6. 6

    Pattern of chemotherapy use at end of life (EOL) in patients with solid tumors (ST) by Burke, Thomas W., DeJesus, Yvette A, Cheng, Lee, Buzdar, Aman, Rodriguez, Maria Alma

    Published in Journal of clinical oncology (01-11-2013)
    “…Abstract only 93 Background: Quality performance measures for cancer care, including use of chemotherapy in the last two-weeks of life, will be required for…”
    Get full text
    Journal Article
  7. 7

    Factors related to end-of-life (EOL) chemotherapy in solid tumor (ST) patients by Rodriguez, Maria Alma, DeJesus, Yvette A, Cheng, Lee, Buzdar, Aman, Burke, Thomas W.

    Published in Journal of clinical oncology (01-11-2013)
    “…Abstract only 92 Background: Quality performance measures for cancer care, including use of chemotherapy in the last two-weeks of life, will be required for…”
    Get full text
    Journal Article
  8. 8

    Pattern of chemotherapy use at end-of-life (EOL) in patients with solid tumors (ST) by Burke, Thomas W., DeJesus, Yvette A, Cheng, Lee, Buzdar, Aman, Rodriguez, Maria Alma

    Published in Journal of clinical oncology (20-05-2013)
    “…Abstract only 9539 Background: Quality performance measures for cancer care, including use of chemotherapy in the last two-weeks of life, will be required for…”
    Get full text
    Journal Article
  9. 9

    Factors related to end-of-life (EOL) chemotherapy in solid tumor (ST) patients by Rodriguez, Maria Alma, DeJesus, Yvette A, Cheng, Lee, Buzdar, Aman, Burke, Thomas W.

    Published in Journal of clinical oncology (20-05-2013)
    “…Abstract only 9538 Background: Oncologists will be required to report quality measures for cancer care, including use of chemotherapy in the last two-weeks of…”
    Get full text
    Journal Article
  10. 10

    Compliance with established pneumonia core measures at MD Anderson Cancer Center in the emergency center by Gonzalez, Carmen E., Johnson, Tami N., Kidin, Lisa M., Evans, Scott, DeJesus, Yvette, Rolston, Kenneth V. I., Walters, Ronald Stewart

    Published in Journal of clinical oncology (01-12-2012)
    “…Abstract only 189 Background: Pneumonia is the major cause of death due to infectious diseases in the United States. In the cancer patient, pneumonia is the…”
    Get full text
    Journal Article
  11. 11

    Using practice algorithms to deliver cancer survivorship care by Palos, Guadalupe R., Zandstra, Fran, Russell, Ludivine, Flores, Jacklyn J, DeJesus, Yvette, Foxhall, Lewis E, Rodriguez, Maria Alma

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e19625 Background: Clinical practice algorithms provide a framework to guide providers’ practice in delivering care to long-term cancer…”
    Get full text
    Journal Article
  12. 12

    Multidisciplinary care clinics: A model to deliver personalized survivorship care by Zandstra, Fran, Palos, Guadalupe R., Russell, Ludivine, Flores, Jacklyn J, DeJesus, Yvette, Foxhall, Lewis E, Rodriguez, Maria Alma

    Published in Journal of clinical oncology (20-05-2012)
    “…Abstract only e19629 Background: Multidisciplinary care models provide a comprehensive approach to improve the care of long-term cancer survivors as…”
    Get full text
    Journal Article
  13. 13

    Usage of erythropoiesis‐stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia by Ferrajoli, Alessandra, Buzdar, Aman U., DeJesus, Yvette, Cheng, Lee, Michaud, Laura B., Rodriguez, Maria A.

    Published in Cancer (15-07-2011)
    “…BACKGROUND: In 2007, the US Food and Drug Administration (FDA) issued regulatory alerts for use of erythropoiesis‐stimulating agents (ESAs) in cancer patients…”
    Get full text
    Journal Article
  14. 14

    Changing Nursing Practice in Survivorship Care With Clinical Decision Tools by Palos, Guadalupe R, Lewis-Patterson, Paula, Gilmore, Katherine, DeJesus, Yvette, Rodriguez, Alma M

    Published in Clinical journal of oncology nursing (01-08-2015)
    “…The paradigm shift to include survivorship care as part of the cancer care continuum underscores the critical need for a change in nursing practice. One way to…”
    Get full text
    Journal Article
  15. 15

    Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways by ANDTBACKA, Robert H. I, BABIERA, Gildy, SINGLETARY, S. Eva, HUNT, Kelly K, MERIC-BERNSTAM, Funda, FEIG, Barry W, AMES, Frederick C, ROSS, Merrick I, DEJESUS, Yvette, KUERER, Henry M

    Published in Annals of surgery (2006)
    “…To minimize treatment variations, we have implemented clinical pathways for all breast cancer patients undergoing surgery. We sought to determine the incidence…”
    Get full text
    Journal Article
  16. 16

    Incidence of pregnancy events among women with a malignant disease diagnosis by Rodriguez, Maria Alma, Cheng, Lee, DeJesus, Alma Yvette, Milbourne, Andrea

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e18262 Background: Pregnancy concurrent with cancer is rare, but adds additional complexity to cancer management and treatment. Little…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20